EPLAW PATENT BLOG

UK – Actavis v Lilly – dextrose

Posted: March 3rd, 2016

(1) Actavis UK Limited (2) Actavis Group EHF (3) Actavis Group PTC EHF (4) Medis EHF (5) Actavis Deutschland GMBH & CO. KG (6) Medis Pharma GMBH (7) Medis Pharma France SAS (8) Actavis France SAS (9) Actavis Spain S.A. (10) Actavis Italy SPA A Socio Unico v Eli Lilly & Company, High Court of […]

READ MORE

UK – Celltrion v. Biogen Idec

Posted: February 25th, 2016

Celltrion Inc v (1) Biogen Idec Inc. (2) F. Hoffmann-La-Roche AG & (3) Genentech Inc., High Court of Justice of England and Wales, Patents Court (Carr J.), London UK, 22 January 2016, Neutral Citation Number: [2016] EWHC 188 (Pat)  On 22 January 2016, Carr J granted the Claimant’s application for an order that its claim […]

READ MORE

UK – Global Flood Defence Systems v. Johan van den Noort / Costs

Posted: February 17th, 2016

Global Flood Defence Systems Limited and UK Flood Barriers Limited v Johan Van Den Noort Beheer BV, Johann Heinrich Reindert Van Den Noort and Flood Control International Limited, High Court of Justice of England and Wales, Intellectual Property Enterprise Court (HHJ Hacon), London UK, 5 February 2016, Neutral Citation Number: [2016] EWHC 189 (IPEC) On […]

READ MORE

UK – Regeneron v. Kymab and Novo Nordisk

Posted: February 16th, 2016

Regeneron Pharmaceuticals Inc v Kymab Limited and Novo Nordisk A/S, High Court of England and Wales (Carr J), London, UK, 1 February 2016, Neutral Citation Number: [2016] EWHC 87 (Pat).  On 3 February 2016 the Patents Court (Carr J) held that the disputed claims of two of Regeneron’s patents relating to transgenic mice used for […]

READ MORE

ES – Gamesa v. Aloys Wobben

Posted: February 15th, 2016

Gamesa v Aloys Wobben, 15th Section of the Provincial Court of Appeals of Barcelona, Spain, 7 January 2016, Docket No. 443/2014-2ª On 14 January 2016, Section 15th of the Provincial Court of Appeals of Barcelona served its decision of 7 January in the GAMESA v. WOBBEN case. This is a very interesting Judgement not only […]

READ MORE

ES – Astrazeneca v. Laboratorios Alter

Posted: February 15th, 2016

On 21st December 2015, The Supreme Court handed down a decision in the case of AstraZeneca AB & others v Laboratorios Alter and & others (EDJ 2015/244058). AstraZeneca had filed an action against several generic companies for infringement of an SPC for the product quetaipina: The SPC’s basic patent was EP 228. EP 228 was […]

READ MORE

UK – Global Flood Defence Systems v. Johann Van Den Noort Beheer

Posted: February 10th, 2016

On 1 February 2016 the Intellectual Property Enterprise Court handed down a decision of Judge Hacon in the case of Global Flood Defence Systems Ltd & others v Johann Van Den Noort Beheer BV & others [2016] EWHC 99 (IPEC) on the subject of groundless threats and fraudulent misrepresentation. The alleged groundless threats were made […]

READ MORE

UK – AP Racing v. Alcon Components

Posted: February 10th, 2016

AP Racing Limited v Alcon Components Limited, High Court of Justice of England and Wales, Intellectual Property Enterprise Court (HHJ Hacon), London UK, 28 January 2016, Neutral Citation Number: [2016] EWHC 116 (IPEC) In an inquiry as to damages, the Intellectual Property Enterprise Court (the “IPEC”) has awarded AP Racing Limited (“AP Racing”) almost £0.5 […]

READ MORE

NL – Warner-Lambert v. Dutch Medicines Evaluation Board

Posted: January 26th, 2016

Warner-Lambert Company LLC v. the State of The Netherlands (Dutch Medicines Evaluation Board), District Court of The Hague, The Netherlands, 15 January 2016, Case file number: C/09/498943 / KG ZA 15-1656 Warner-Lambert Company LLC is part of the Pfizer group of companies (hereinafter: “WLC”). Pfizer brings a medicine on the market (including The Netherlands) under […]

READ MORE